Corrigendum to: Follistatin is a novel therapeutic target and biomarker in FLT 3/ ITD acute myeloid leukemia (EMBO Molecular Medicine, (2020), 12, 4, 10.15252/emmm.201910895)
Embo Molecular Medicine(2020)
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要